WRF
NEO icon

Waddell & Reed Financial’s NeoGenomics NEO Stock Holding History

Waddell & Reed Financial’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$43.3M Sell
897,051
-157,213
-15% -$8.18M 0.09% 271
2020
Q4 		$56.8M Sell
1,054,264
-34,856
-3% -$1.58M 0.12% 199
2020
Q3 		$40.2M Buy
1,089,120
+861,976
+379% +$32M 0.1% 235
2020
Q2 		$7.04M Buy
+227,144
New +$6.29M 0.02% 402

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
KFO
Kopp Family Office Bloomington, Minnesota $163M AUM 22.57% 1-Year Est. Return

Waddell & Reed Financial's NEO Position: Q1 2021 in Review

Waddell & Reed Financial reduced its NeoGenomics (NEO) stake by 15% in Q1 2021, selling an estimated $8.18M and leaving 897,051 shares worth $43.3M. The position accounts for 0.09% of the portfolio, ranked #271.

Waddell & Reed Financial first reported a position in NEO in Q2 2020 and has held it in 4 quarters since. The position peaked at $56.8M in Q4 2020. 332 funds tracked by Wall St. Rank hold NEO as of Q1 2021.

  • Waddell & Reed Financial held 897,051 shares of NeoGenomics worth $43.3M as of Q1 2021.
  • Waddell & Reed Financial sold 157,213 NeoGenomics shares in Q1 2021, an estimated $8.18M.
  • NeoGenomics made up 0.09% of Waddell & Reed Financial's portfolio in Q1 2021, its #271 holding.
  • Waddell & Reed Financial first reported a position in NeoGenomics in Q2 2020 and has held it in 4 quarters since.
  • Waddell & Reed Financial's NeoGenomics position peaked at $56.8M in Q4 2020.
  • 332 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2021.

Based on Waddell & Reed Financial's 13F filing for Q1 2021, filed 12 May 2021.